• AAPL 165
  • TSLA 147.05
  • AMZN 174.63
  • MSFT 399.12
  • INTC 34.2
  • EURUSD 1.0661
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. ST /
  3. ATORX.ST

Alligator Bioscience AB (ATORX ST) stock market data APIs

kr1.18 0.16(15.7%) as of April 19, 2024

Alligator Bioscience AB Financial Data Overview

1.438
1.18
-
1.444
0.55
0.34-1.568
670 M
658 M
59 251 K
1.34
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ATORX',
Type: 'Common Stock',
Name: 'Alligator Bioscience AB',
Exchange: 'ST',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'Sweden',
CountryISO: 'SE',
OpenFigi: NULL,
ISIN: 'SE0000767188',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Alligator Bioscience AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 59 251 K
  • EBITDA -248 242 000
  • Earnings Per Share -0.55
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Alligator Bioscience AB Earnings via APIs

  • Latest Release 2024-04-25
  • EPS/Forecast NaN

Get Alligator Bioscience AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Alligator Bioscience AB latest news via APIs

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

LUND, Sweden, Jan. 19, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the initiation a sponsored research collaboration to study biomarker data from Alligator's OP...
  • ALLIGATOR
  • BEATTY
  • BIOSCIENCE
  • GREGORY BEATTY
  • NASDAQ STOCKHOLM
  • UNIVERSITY OF PENNSYLVANIA

Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects Reported

LUND, Sweden, Jan. 18, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going OPTIMIZE-1 clinical Phase Ib/II trial with the company's lead asset...
  • ALLIGATOR
  • BIOSCIENCE
  • CLINICAL PHASE
  • LUND
  • NASDAQ STOCKHOLM
  • SWEDEN
Do you have any questions?
support@eodhistoricaldata.com